BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/25/2024 7:15:47 AM | Browse: 243 | Download: 738
 |
Received |
|
2024-03-18 09:10 |
|
Peer-Review Started |
|
2024-03-18 09:11 |
|
First Decision by Editorial Office Director |
|
2024-05-16 00:39 |
|
Return for Revision |
|
2024-05-16 00:39 |
|
Revised |
|
2024-05-28 13:03 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-06-06 02:58 |
|
Second Decision by Editor-in-Chief |
|
2024-06-07 19:40 |
|
Final Decision by Editorial Office Director |
|
2024-06-24 08:30 |
|
Articles in Press |
|
2024-06-24 08:30 |
|
Edit the Manuscript by Language Editor |
|
2024-06-30 21:07 |
|
Typeset the Manuscript |
|
2024-07-09 07:22 |
|
Publish the Manuscript Online |
|
2024-07-25 07:15 |
| ISSN |
1948-0210 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Review |
| Article Title |
Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Prashasti Sharma and Dharmendra Kumar Maurya |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Dharmendra Kumar Maurya, BSc, MSc, PhD, N/A, N/A, Radiation Biology & Health Sciences Division, Bhabha Atomic Research Centre, 3-82-S, A-block, Modular Laboratory, Mumbai 400085, Maharashtra, India. dkmaurya@barc.gov.in |
| Key Words |
Stem cells; Wharton’s jelly mesenchymal stem cells; Radiotherapy; Xerostomia; Lung fibrosis |
| Core Tip |
Stem cells, particularly Wharton’s Jelly mesenchymal stem cells (WJ-MSCs), are pivotal in cell-based therapy due to their robust tissue repair abilities. While radiotherapy is a common cancer treatment, it often causes collateral damage to healthy tissues, reducing its efficacy. WJ-MSCs, resembling embryonic stem cells, exhibit superior differentiation and safety, making them ideal for both autologous and allogeneic transplants. This review emphasizes WJ-MSCs’ regenerative potential and clinical utility in alleviating radiation-induced injuries resulting from radiotherapy across various cancer types. |
| Publish Date |
2024-07-25 07:15 |
| Citation |
Sharma P, Maurya DK. Wharton’s jelly mesenchymal stem cells: Future regenerative medicine for clinical applications in mitigation of radiation injury. World J Stem Cells 2024; 16(7): 742-759 |
| URL |
https://www.wjgnet.com/1948-0210/full/v16/i7/742.htm |
| DOI |
https://dx.doi.org/10.4252/wjsc.v16.i7.742 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
